Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ Hq$?-%4
V5LzUg]
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© G_x<2E"d
Go_~8w0<
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© UYb:q
co%ttH\ n
1.Co-stimulators (or co-stimulating molecules) ] Vbv64M3
F\;G'dm
2.NK-kB {)0"?$C_H
Hi<5jl
3.Immunoglobulin superfamily t|aBe7t7
vN%SN>=L<
4.antigen-presenting cell (APC) g k[
8'
h~
=UFE%'
5.death domain @
zE>n
/_P5UE(
6.CCR and CXCR y++[:M
<x),HTJ
7.Lectin (or mitogen) :
)\<
=5jX#Dc5.+
8.Clusters of differentiation, CD) >I3#ALF
G~I@'[ur
9.B7 family gI
qYIt
c?{&=,u2
10.Cytotoxic T lymphocyte, CTL) ~ b;%J:
g,!6,v@
11.IL-15 and IL-15 receptor (IL-15R) jLf. qf8qm
*;wPAQE
12.MHC restriction R*D0A@
~JsTHE$F
13.Affinity-chromatography ~
FW@
2Ke?*
14.Cyctosprin A, CsA wG4=[d
p*8LS7UT
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) YT6<1-E#
:e5)Q=lX
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© {i)k# `
~*9
vn Z@
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *4;MO2g
E-_FxBw
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ L<encPJt
NWuS/Ur`9
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ |T~C($9
Y#EM]x5!=
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© }u0t i"V
/pZ]:.A
ÃâÒßѧרҵ£º 4i>sOP3
B
)2KQZMtgm]
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ y-qbK0=X4
*P,dR]-m
Ïû»¯ÄÚ¿Æ£º lL.3$Rp;
h=uwOi6}
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ M[N$N`9
LwQq0<v
ѪҺ²¡Ñ§×¨Òµ£º 8y5iT?.~vy
O)78
iEXi|
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿